December 2018
Slides for webinar can be downloaded here:
Accumulating evidence shows that eating later in the evening as well as nighttime eating are associated with cardiometabolic disease and cancer risk. Daily practice of fasting during inactive, “sleep” phases of the circadian clock is associated with improved metabolic and breast cancer outcomes. Suggestive evidence supports metabolic benefits and safety of intermittent fasting, however, compliance challenges exist for fasting during “active” phases of day. Evidence-based messaging about health-promoting, food intake timing could have a significant public health benefit. Participants will leave the webinar better informed on how intermittent fasting may be effective in reducing cardio metabolic and cancer disease risk in some individuals, and how best to communicate and practically implement this strategy.
Dorothy Sears, Ph.D. is Professor of Nutrition at the College of Health Solutions at Arizona State University and Adjunct Professor of Medicine and Family Medicine & Public Health at UC San Diego. She completed her undergrad at University of Southern California and earned her Ph.D. in Molecular Biology and Genetics from Johns Hopkins University School of Medicine. Her research interests include insulin resistance, type 2 diabetes, eicosanoids, obesity, metabolic regulation, and breast cancer. Her goals are to identify and characterize genes, metabolites and metabolic pathways that regulate and/or are biomarkers of insulin resistance and breast cancer and which can be used as novel therapeutic targets or diagnostic tools. Dr. Sears has been conducting obesity and obesity-related disease research since 1995 and is an internationally recognized expert. She has authored and co-authored numerous articles on topics relating to insulin resistance and adipose tissue inflammation. In addition, she is passionate about mentoring and supporting women in STEM-related fields and participates heavily in outreach programs for young adults.
Title: The Evidence: Impact of Intermittent Fasting and Food Intake Timing on Cardiometabolic Disease and Cancer Risk
Date: Wednesday, December 12, 2018
Time: 12:00PM - 1:00PM EST
CE Credit: 1.0 contact hour, 1.0 CPEU
Upon completing this activity, the learner will be able to:
1. Describe intermittent fasting, including the variety of intermittent fasting regimens and the challenges associated with implementation.
2. Identify the evidence-supported health effects of intermittent fasting, shorter fasting times, and food intake timing related to cancer, obesity, and type 2 diabetes
3. Discuss the use of fasting and food intake timing regimens that may be aligned with circadian rhythm.
Click here to register for this FREE webinar!
Visit villanova.edu/COPE or email COPE@villanova.edu to join our Contact list or to become a COPE Sponsor. A non-profit center, COPE is based in the M. Louise Fitzpatrick College of Nursing at Villanova University. COPE supports and develops educational programs for health professionals, educators, worksites and the public.
Details on CE Credits
Neither the planners nor presenter have any disclosures to report.
To receive a CE certificate, you must individually register online for the webinar, attend the full program and complete an online evaluation.
Villanova University College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center Commission on Accreditation.
Villanova University College of Nursing MacDonald Center for Obesity Prevention and Education is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1 Continuing Professional Education unit (CPEU) for completion of this activity.
The American College of Sports Medicine’s Professional Education Committee certifies that Villanova University College of Nursing Continuing Education/ Center for Obesity Prevention and Education (COPE) meets the criteria for official ACSM Approved Provider status (December 2015-2018). Providership # 698849